Page last updated: 2024-10-29

isoproterenol and Peripheral Vascular Diseases

isoproterenol has been researched along with Peripheral Vascular Diseases in 1 studies

Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.

Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xu, C1
Tang, F1
Lu, M1
Yang, J1
Han, R1
Mei, M1
Hu, J1
Zhou, M1
Wang, H1

Other Studies

1 other study available for isoproterenol and Peripheral Vascular Diseases

ArticleYear
Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways.
    International immunopharmacology, 2016, Volume: 33

    Topics: Animals; Anti-Inflammatory Agents; Aorta; Astragalus propinquus; Cardiomegaly; Cytokines; Humans; Is

2016